Complement dysregulation in human tauopathies
Jacqui Nimmo(UK Dementia Research Institute), B. Paul Morgan(UK Dementia Research Institute), Louis De Muynck(Janssen (Belgium)), Samuel Keat(UK Dementia Research Institute)
Cited by 2
Related Papers
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
|Acta Neuropathologica Communications|2022|97
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
|Alzheimer s Research & Therapy|2020|48
The complement system in neurodegenerative diseases
|Clinical Science|2024|48
The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy
|International Journal of Molecular Sciences|2020|47
PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
|Journal of Biological Chemistry|2021|41